MENU
CORT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Corcept Therapeutics (CORT) Ownership - Who owns Corcept Therapeutics?
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol... Show more
Industry: #Pharmaceuticals Other
Profile
Industry
Pharmaceuticals Other
Address
149 Commonwealth Drive
Phone
+1 650 327-3270
Employees
352
Web
https://www.corcept.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
7.88B
P/E Ratio
64.63
Total Cash
322.76M
Projected Growth
N/A
Total Debt
6.84M
Revenue
685.45M
Risk (Beta)
0.38
Dividend Yield
N/A
Total Cash/Share
3.04
Total Debt/Equity
374.71
Revenue/Share
5.91 USD as % of share price
Fundamentals
CORT
Capitalization
7.88B
P/E Ratio
64.63
Risk (Beta)
0.38
Dividend Yield
N/A
Total Cash
323M
Total Cash/Share
3.04
Total Debt
6.84M
Total Debt/Equity
374.71
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
5.91%
Revenue
685M
ROE
N/A
Book Value
683M
P/B Ratio
11.53
Cash Flow
N/A
Earnings
1.27
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
137K
Current Ratio
3.07
Current Revenue Per Employee
314428.00
Dividends Per Share - Security
N/A
EBITDA
112M
Float
N/A
Float - Current
N/A
Gross Income Margin
98.47
Revenue To Assets
17.64
Shares Held By Institutions
11.2B
Shares Outstanding - Current
106M
Total Liabilities
163M
Total Volume MTD
N/A
Value
-1
Gain YTD
47.509
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a maker of drugs for the treatment of severe psychiatric and neurological diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
149 Commonwealth Drive
Phone
+1 650 327-3270
Employees
352
Web
https://www.corcept.com